Hannigan A, Smith P, Kalna G, Nigro, CL, Orange C, O’Brien DI, Shah R, Syed N, Spender LC, Herrera JK, Thurlow JK, Lattanzio L, Monteverde M, Maurer ME, Buffa FM, Mann J, Chu DCK, West CML, Partridge M, Oien KA, Cooper JA, Frame MC, Harris AL, Hiller L, Nicholson LJ, Gasco M, Crook T, Inman GJ. Epigenetic downregulation of human disabled homolog 2 switches TGF-b from a tumor suppressor to a tumor promoter. J. Clin. Invest. (In press – 2010).
Harley ME, Allan LA, Sanderson H, Clarke P. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J. (Epub ahead of print – 2010).
Maertens GN, El Messaoudi-Aubert S, Elderkin S, Hiom K, Peters G. Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. EMBO J. (Epub ahead of print – 2010).
Staples CJ, Owens DM, Maier JV, Cato AC, Keyse SM. Crosstalk between the p38{alpha} and JNK MAP kinase pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation. J Biol Chem. (Epub ahead of print – 2010).
Zhang Y, Hayes JD. Identification of topological determinants in the N-terminal domain of transcription factor Nrf1 that control its orientation in the endoplasmic reticulum membrane. Biochem J. (Epub ahead of print – 2010).
Beall C, Piipari K, Al-Qassab H, Smith MA, Parker N, Carling D, Viollet B, Withers DJ, Ashford ML. Loss of AMP-activated protein kinase alpha2 subunit in mouse beta-cells impairs glucose-stimulated insulin secretion and inhibits their sensitivity to hypoglycaemia. Biochem J. (Epub ahead of print – 2010).
Logie L, Ruiz-Alcaraz AJ, Schofield CJ, Hundal HS, Feuerstein GZ, Brady JD, Crowther D, Tommasi AM, Grierson CE, Shepherd B, Morris AD, Hansen MK, Pearson E, Sutherland C. Generation, validation and humanisation of a novel insulin resistant cell model. Biochem. Pharm. (in press - 2010).
Steele AM, Shields BM, Shepherd M, Ellard S, Hattersley AT, Pearson ER. Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene. Diabet Med. 27 157-61 (2010).
Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, Petrie JR. The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia. 2010 May;53(5):809-20
Voight BF, Scott LJ, Steinthorsdottir V, et al MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 42 579-89 (2010).
Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. (Epub ahead of print – 2010).
Zhou L, Podolsky N, Sang Z, Ding Y, Fan X, Tong Q, Levin BE, McCrimmon RJ. The medial amygdalar nucleus: A novel glucose-sensing region that modulates the counterregulatory response to hypoglycemia. Diabetes. (Epub ahead of print – 2010).
Finn, R.D., McLaughlin, L.A., Hughes, C., Song, C., Henderson, C.J. and Wolf, C.R. Cytochrome b5 null mouse: a new model for studying inherited skin disorders and the role of unsaturated fatty acids in normal homeostasis. Transgenic Res. (2010 – in press).
Scheer N, Ross J, Kapelyukh Y, Rode A, Wolf CR. In vivo responses of the human and murine pregnane X receptor to dexamethasone in mice. Drug Metab Dispos. (Epub ahead of print – 2010).
Singh R, Arlt VM, Henderson CJ, Phillips DH, Farmer PB, Costa GG. Detection and quantitation of N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine adducts in DNA using online column-switching liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. (Epub ahead of print – 2010).
Williamson PA, Short PM, McKinlay L, Palmer CN, Lipworth BJ. {beta}-agonist safety and the elephant in the room? Thorax. (Epub ahead of print – 2010).
Young R, Wolf CR, Brown K, Hayes JD, Whitelaw CB. Spatial monitoring of toxicity in HMOX-LacZ transgenic mice. Transgenic Res. (Epub ahead of print – 2010).
Jafferbhoy H, Gashau W, Dillon JF. Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection. ClinicoEconomics Outcomes Res. (In press – 2010).
McDonald SA, Hutchinson SJ, Bird SM, Mills PR, Hayes PC, Dillon JF, Goldberg DJ. Excess morbidity in the hepatitis C diagnosed population in Scotland 1991-2006 Epidemiol. Infect. (In press – 2010).
McDonald SA, Hutchinson SJ, Bird SM, Robertson C, Mills PR, Dillon JF, Goldberg DJ. Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: Increased risk following diagnosis with hepatitis C infection. Int J Drug Policy. (Epub ahead of print – 2010).
Tait JM, McIntyre PG, McLeod S, Nathwani D, Dillon JF. MCN The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre. J. Vir. Hepat. (Epub ahead of print – 2010).
Young R, Hayes JD, Brown K, Wolf CR, Whitelaw CB. Peroxiredoxin Gene Expression Signatures in Liver Reflect Toxic Insult. Assay Drug Dev Technol. (Epub ahead of print – 2010).
Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson M. Cellular stress responses, the hormesis paradigm and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal. (Epub ahead of print – 2010).
Clayton, E.L., Sue, N., Smillie, K.J., O'Leary, T., Bache, N., Cheung, G., Cole, A.R., Wyllie, D.J., Sutherland, C., Robinson, P.J., and Cousin, M.A. Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles. Nat.Neurosci. (Epub ahead of print – 2010).
Deldicque L, Cani PD, Philp A, Raymackers JM, Meakin PJ, Ashford ML, Delzenne NM, Francaux M, Baar K. The unfolded protein response is activated in skeletal muscle by high-fat feeding: potential role in the down-regulation of protein synthesis. Am J Physiol Endocrinol Metab. (Epub ahead of print – 2010).
McNay EC, Ong CT, McCrimmon RJ, Cresswell J, Bogan JS, Sherwin RS. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem. 93 546-53 (2010).
Soutar MPM., Kim W-Y., Williamson R., Peggie M., Hastie CJ., McLauchlan H., Snider WD., Gordon-Weeks PR. and Sutherland, C. Evidence that Glycogen Synthase Kinase-3 isoforms have distinct substrate preference in the brain. J.Neurochemistry (In press - 2010).
Luciano M, Batty D, McGilchrist M, Linksted P, Fitzpatrick B, Jackson C, Pattie A, Dominiczak, Morris AD, Smith BH, Porteous D, Deary IJ. Shared genetic aetiology between cognitive ability and cardiovascular disease risk factors: Generation Scotland’s family health study. Intelligence 38 304-313 (2010).
Mukhopadhyay S, Sypek J, Tavendale R, Gartner U, Winter J, Li W, Page K, Fleming M, Brady J, O'Toole M, Macgregor DF, Goldman S, Tam S, Abraham W, Williams C, Miller DK, Palmer CN. Matrix metalloproteinase-12 is a therapeutic target for asthma in children and young adults. J Allergy Clin Immunol. (Epub ahead of print – 2010).
Northwood, E.L., Elliott, F., Forman, D., Barrett, J.H., Wilkie, M.J.V., Carey, F.A., Steele, R.J.C., Wolf, C.R., Bishop, D.T. and Smith, G. Polymorphisms in xenobiotic metabolising enzymes and diet influence colorectal ademona risk. Pharmacogenetics & Genomics. 20 315-26 (2010).
Romanowska M, Reilly L, Palmer CN, Gustafsson MC, Foerster J. Activation of PPARbeta/delta Causes a Psoriasis-Like Skin Disease In Vivo. PLoS One. 5 e9701 (2010).
del.icio.us
digg
reddit
facebook
stumbleupon